Anti-ganglioside complex antibodies associated with severe disability in GBS
- 31 January 2007
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 182 (1-2) , 212-218
- https://doi.org/10.1016/j.jneuroim.2006.09.013
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (16590854)
- Ministry of Health, Labour and Welfare (H15-015)
This publication has 19 references indexed in Scilit:
- Effects of phospholipids on antiganglioside antibody reactivity in GBSJournal of Neuroimmunology, 2005
- Ganglioside complexes as new target antigens in Guillain–Barré syndromeAnnals of Neurology, 2004
- Binding of immunoglobulin G antibodies in Guillain–Barré syndrome sera to a mixture of GM1 and a phospholipid: Possible clinical implicationsMuscle & Nerve, 2003
- Structure ofCampylobacter jejuniLipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher PatientsInfection and Immunity, 2002
- Guillain–Barré syndrome with IgM antibody to the ganglioside GalNAc–GD1aPublished by Elsevier ,2001
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- Serum anti‐GQ 1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndromeNeurology, 1993
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- STALOSYLGALACTOSYL CERAMTDE AS A SPECIFIC MARKER FOR HUMAN MYELIN AND OLIGODENDROGLIAL PERIKARYA: GANGLIOSIDES OF HUMAN MYELIN, OLIGODENDROGLIA AND NEURONSJournal of Neurochemistry, 1979
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978